BusinessETST Announces Recruitment of Key Individuals for its Two Subsidiaries and the Leasing of a Manufacturing Facility to Produce its MSN-2 Medical Device.By Nasdaq OMXMar 14, 2017, 12:01 PM UTC
BusinessNexeo Solutions Continues to Build Capability in Specialty Chemicals with Agreement to Acquire Ultra ChemBy Nasdaq OMXMar 9, 2017, 9:06 PM UTC
BusinessETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & NutraceuticalsBy Nasdaq OMXFeb 14, 2017, 12:15 PM UTC
BusinessWABCO Extends Long-Term Supply Agreement for Advanced Technologies with KAMAZ, Russia’s Largest Maker of Heavy-Duty Trucks; Secures Incremental BusinessBy Nasdaq OMXFeb 1, 2017, 10:30 AM UTC
BusinessEarth Science Tech, Enters Multi-Billion Dollar Sports Supplement Industry via Joint Venture with Nutrition Specialties and ForzagenBy Nasdaq OMXJan 31, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio CastilloBy Nasdaq OMXJan 25, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Signs Marketing & Media Agreement with Pearls of Health and Appoints Gabriel Aviles as Chief Sales Officer (CSO).By Nasdaq OMXJan 9, 2017, 12:45 PM UTC
BusinessLeucadia and FXCM Complete Long-Term Partnership AgreementBy Nasdaq OMXSep 1, 2016, 11:30 AM UTC
